Thalassaemia is the most common genetic blood disorder in the world. China currently has 30 million thalassaemia gene carriers, while the global total reaches 350 million.Severe thalassaemia patients could confront a stark reality: regular blood transfusions, potential organ transplants, even the risk of premature death.If two carriers of the gene marry, their children have a 25 per cent chance of developing the disease.China’s latest original therapy, which integrates gene editing and stem...